Bilal Omer, MD

MultiTAA-specific T cells

Dose Level 1B: 2 x 10^7 cells/m2

Dose Level 1A: 2 x 10^7 cells/m2

Dose Level 3B: 2 x 10^8 cells/m2

Dose Level 2B: 6 x 10^7 cells/m2

Multivirus Specific T cells

Dose Level 1 (starting dose level)

not_applicable

allovir

Chimeric Antigen Receptor Treatment Targeting CD70 (SEVENTY)

+7 more interventions

15 unique interventions3 categories

Analytics

Trial Phases

Phase 16

Trial Status

Completed2

Recruiting3

Other2

Role Distribution

Principal Investigator7

PI Rate100%

Activity Timeline

Clinical Trials (7)

NCT06345027Phase 1Recruiting

Leukemia, B-cellLeukemia, Myeloid, AcuteLeukemia, T-Cell

PrincipalinvestigatorStart date: 2026-04-15

NCT04664179Phase 1Recruiting

EBV Specific T-Lymphocytes for Treatment of EBV-Positive Lymphoma

EBV Related Non-Hodgkin's LymphomaEBV-Related Hodgkin LymphomaEBV-Related Lymphoproliferative Disorder

PrincipalinvestigatorStart date: 2022-10-31

NCT04099797Phase 1Recruiting

C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

Diffuse Intrinsic Pontine GliomaEmbryonal TumorEpendymal Tumor+1 more

PrincipalinvestigatorStart date: 2020-02-03

NCT03635632Phase 1Active Not Recruiting

C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)

Phyllodes Breast TumorRefractory NeuroblastomaRelapsed Ewing Sarcoma+4 more

PrincipalinvestigatorStart date: 2019-04-23

NCT02108522Not ApplicableCompleted

Multivirus-specific T Cells for the Treatment of Virus Infections After Stem Cell Transplant

Infection

Principalinvestigator

NCT02475707Phase 1Completed

Administration of Donor MultiTAA-Specific T Cells for ALL

Leukemia, Lymphoblastic (Acute)

Principalinvestigator

NCT07297160Phase 1Withdrawn

CD70.CAR for CD70+ Lymphoma, Myeloma and Solid Tumors

Kidney CancerLymphomaMyeloma+2 more

Principalinvestigator

Research Network

Collaboration Network

3 collaborators·2 connections

Network Legend

KOL

Current Investigator

High-influence Collaborator

Collaborator

Click: view details

Double-click: go to profile

Drag: move node

Research Areas & Affiliations

Therapeutic Areas

Diffuse Intrinsic Pontine Glioma1 EBV Related Non-Hodgkin's Lymphoma1 EBV-Related Hodgkin Lymphoma1 EBV-Related Lymphoproliferative Disorder1 Embryonal Tumor1 Ependymal Tumor1 High Grade Glioma1 Infections1

Affiliations

Baylor College of Medicine

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Jasia Mahdi, MD

Baylor College of Medicine

Moderately Similar

2 trials

Shared therapeutic areas:

Diffuse Intrinsic Pontine GliomaEmbryonal TumorEpendymal Tumor+1 more

Worked with same sponsors:

Baylor College of MedicineCancer Prevention Research Institute of Texas+5 more

Collaborated on 1 trial

Similarity Score44%

Jorge Cortes, MD

M.D. Anderson Cancer Center

24 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaInfections+1 more

Worked with same sponsors:

National Cancer Institute (NCI)

Similarity Score5%

Tanya Trippett, MD

Memorial Sloan Kettering Cancer Center

13 trials

Shared therapeutic areas:

LymphomaSarcomaSolid Tumors

Worked with same sponsors:

National Cancer Institute (NCI)

Similarity Score4%

Guillermo Garcia-Manero, MD

M.D. Anderson Cancer Center

18 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcutePrecursor Cell Lymphoblastic Leukemia-LymphomaSolid Tumors

Similarity Score4%

Areej El-Jawahri, MD

Massachusetts General Hospital

21 trials

Shared therapeutic areas:

Leukemia, Myeloid, AcuteLymphoma

Worked with same sponsors:

National Cancer Institute (NCI)

Similarity Score3%

Seetha Shankaran, MD

Wayne State University

49 trials

Shared therapeutic areas:

Dale L. Phelps, MD

University of Rochester

10 trials

Shared therapeutic areas:

Abhik Das, PhD

RTI International

31 trials

Shared therapeutic areas:

Michele C. Walsh, MD MS

Case Western Reserve University, Rainbow Babies and Children's Hospital

11 trials

Shared therapeutic areas:

Hagop Youssoufian, MD

Verastem, Inc.

20 trials

Shared therapeutic areas:

Lymphoma